Activated NKG2D on NK cells recognizes NKG2D ligands (MICA/B and ULBPs) and enables the induction of NK-cell-mediated cytotoxicity on AML cells [115,116]. This evidence concerns the gene KLRK1 and acute myeloid leukemia.